860 CD40 agonism is required to promote the function of cross-presenting dendritic cells and increase triple negative breast cancer response to radiation and CTLA4 inhibition
| Published in: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|